Skip to content

Myocardial infarction risk rises with each year of antiretroviral therapy, but remains low

Investigational NNRTI TMC278 swiftly cuts viral load in treatment-naive patients

Therapeutic vaccine plus interleukin-2 shows best viral control in treatment breaks

Pre-exposure prophylaxis may only offer limited benefit

Vanguard treatment programmes pave the way to scale up

Little difference in child transmission rates between formula feed and breast-plus-AZT

Two new drug classes given to people with HIV for the first time

Pregnant women with CD4 cell counts over 250 not at greater risk of nevirapine-related toxicity in Kenyan study

Therapeutic range for atazanavir defined